Boothbay Fund Management’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Other funds holding IONS
Boothbay Fund Management's IONS Position: Q3 2026 in Review
Boothbay Fund Management sold out of Ionis Pharmaceuticals (IONS) in Q3 2026, closing a stake of 11,808 shares — an estimated $671K sold.
Boothbay Fund Management first reported a position in IONS in Q3 2025 and held it in 4 quarters. The position peaked at $10.7M in Q3 2025. 448 funds tracked by Wall St. Rank hold IONS as of Q3 2026.
- Boothbay Fund Management reported no remaining Ionis Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Boothbay Fund Management sold 11,808 Ionis Pharmaceuticals shares in Q3 2026, an estimated $671K.
- Boothbay Fund Management first reported a position in Ionis Pharmaceuticals in Q3 2025 and held it in 4 quarters.
- Boothbay Fund Management's Ionis Pharmaceuticals position peaked at $10.7M in Q3 2025.
- 448 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.
Based on Boothbay Fund Management's 13F filing for Q3 2026, filed 16 Nov 2026.